Visterra
Founded in 2007 and headquartered in Waltham, Massachusetts, Visterra is a clinical-stage biotechnology company that creates antibody-based therapies for the treatment of patients with kidney disease and other hard-to-treat diseases.
Last updated on
About Visterra
Founded
2007Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$125MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologySIC Code
28NAICs Code
32Location
City
WalthamState
MassachusettsCountry
United StatesTech Stack (65)
